4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001562180-19-003915
Chief Executive Officer sold 33,031 shares at an average $212.60 ($7,022,524)
- Chief Executive Officer acquired 33,031 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kummeth Charles R. Chief Executive Officer | 2019-07-08 | Option exercise | +17,994 | $67.46 | $1,213,875 | 110,170 | D: show line 1 in the form |
| Kummeth Charles R. Chief Executive Officer | 2019-07-08 | Sale | −17,994 | $212.75 | $3,828,184 | 92,176 | D: show line 2 in the form |
| Kummeth Charles R. Chief Executive Officer | 2019-07-09 | Option exercise | +15,037 | $67.46 | $1,014,396 | 107,213 | D: show line 3 in the form |
| Kummeth Charles R. Chief Executive Officer | 2019-07-09 | Sale | −15,037 | $212.43 | $3,194,340 | 92,176 | D: show line 4 in the form |
| Open-market sales · 33,031 sh · avg $212.60 · $7,022,524 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kummeth Charles R. Chief Executive Officer | 2019-07-08 | Option exercise · Stock Options (Right to buy) | −17,994 | 32,006 | D: show line 5 in the form | |||||
| Kummeth Charles R. Chief Executive Officer | 2019-07-09 | Option exercise · Stock Options (Right to buy) | −15,037 | 16,969 | D: show line 6 in the form |
Loading xslF345X03/primarydocument.xml…